KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Non-Current Assets (2016 - 2026)

Pfizer has reported Non-Current Assets over the past 18 years, most recently at $165.2 billion for Q1 2026.

  • Quarterly Non-Current Assets rose 1.86% to $165.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $651.8 billion through Mar 2026, down 6.28% year-over-year, with the annual reading at $3.3 billion for FY2025, 2.3% up from the prior year.
  • Non-Current Assets was $165.2 billion for Q1 2026 at Pfizer, up from $3.3 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $178.7 billion in Q1 2024 and troughed at $3.0 billion in Q4 2023.
  • The 5-year median for Non-Current Assets is $145.5 billion (2023), against an average of $113.2 billion.
  • Year-over-year, Non-Current Assets dropped 15.41% in 2022 and then soared 300.49% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $3.0 billion in 2022, then dropped by 0.17% to $3.0 billion in 2023, then rose by 7.11% to $3.2 billion in 2024, then grew by 2.3% to $3.3 billion in 2025, then soared by 4909.95% to $165.2 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Non-Current Assets are $165.2 billion (Q1 2026), $3.3 billion (Q4 2025), and $162.1 billion (Q3 2025).